Dermapharm Holding SE header image

Dermapharm Holding SE

DMP

Equity

ISIN DE000A2GS5D8 / Valor 40166352

Xetra (2026-02-12)
EUR 36.90-0.27%

Dermapharm Holding SE
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Dermapharm Holding SE is a pharmaceutical company that operates through its subsidiary HÜBNER Naturarzneimittel GmbH, also known as MEDOPHARM Arzneimittel GmbH & Co. KG. Founded in 1932 in Munich, the company specializes in natural preparations for pharmacies, particularly silica products. Dermapharm is a leading manufacturer of branded pharmaceuticals, medical devices, and food supplements, with a focus on steroids, dermatics, and painkillers. The company's integrated business model includes in-house development, production, and distribution of healthcare products in Germany, Europe, and the United States. With a strong emphasis on innovation and rapid growth, Dermapharm is dedicated to providing high-quality pharmaceuticals and healthcare products to its customers.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-4.40%1Y
-3.10%3Y
-41.3%5Y

Performance

24.6%1Y
27.3%3Y
30.7%5Y

Volatility

Market cap

2358 M

Market cap (USD)

Daily traded volume (Shares)

6,183

Daily traded volume (Shares)

1 day high/low

38.55 / 37.75

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Novartis Inc
Novartis Inc Novartis Inc Valor: 1200526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.57%CHF 123.80
PolyPeptide Group Ltd
PolyPeptide Group Ltd PolyPeptide Group Ltd Valor: 111076085
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.65%CHF 25.70
Savaria Corp
Savaria Corp Savaria Corp Valor: 1385257
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.94%CAD 24.71
Johnson & Johnson
Johnson & Johnson Johnson & Johnson Valor: 943981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.53%USD 244.55
Novo Nordisk A/S
Novo Nordisk A/S Novo Nordisk A/S Valor: 461641
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.39%USD 48.93
Merck & Co Inc
Merck & Co Inc Merck & Co Inc Valor: 10683053
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.06%USD 119.24
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.94%USD 27.47
Abbott Laboratories
Abbott Laboratories Abbott Laboratories Valor: 903037
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.87%USD 111.47
Essity AB
Essity AB Essity AB Valor: 36846754
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.98%SEK 283.50
Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc Zimmer Biomet Holdings Inc Valor: 1262932
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.45%USD 95.18